Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 885 of 6351
-
New heart device could free AFib patients from blood thinners
Disease control OngoingThis is an early feasibility study is to evaluate the safety and effectiveness of the Laminar Left Atrial Appendage Closure System to treat patients with non-valvular atrial fibrillation that cannot take, or a have a reason to seek an alternative, to anticoagulant medications.
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Sleep therapy may curb teen suicide risk
Symptom relief Recruiting nowThis study will test the effectiveness of a sleep-related primary suicide prevention program entitled TAILOR (Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior), which includes specific behavior-change strategies for adolescents at risk of suicidal behavio…
Sponsor: Jeff Bridge • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New drug shows promise for rare blood disorder
Disease control CompletedThe purpose of the study is to determine the efficacy of pegcetacoplan administration compared to placebo in increasing hemoglobin (Hgb) level from baseline and avoiding transfusion in participants with primary cold agglutinin disease (CAD).
Phase 3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Could an arthritis drug boost chemo for lung cancer?
Disease control Recruiting nowThe purpose of the study is to explore adding the study drug certolizumab to standard chemotherapy as it may reduce the inflammation caused by the cancer and make the chemotherapy more effective in shrinking the cancer. This study will examine whether adding certolizumab to the u…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New combo therapy hopes to tackle rare skin cancer
Disease control Recruiting nowThis phase II trial studies the effect of extracorporeal photopheresis (ECP) and mogamulizumab in treating patients with erythrodermic cutaneous T cell lymphoma (CTCL), a type of skin lymphoma. CTCL is a rare type of cancer that begins in the white blood cells called T cells. Ery…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug aims to shield brain cells during emergency stroke procedure
Disease control CompletedA Randomized, Placebo-Controlled, Double-Blind, Multicenter Study of the Safety and Neuroprotective Capacity of Scp776 in Subjects Undergoing Endovascular Thrombectomy for Acute Ischemic Stroke
Phase 2 • Sponsor: Silver Creek Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New hope for men with early spread prostate cancer: targeted radiation trial
Disease control Recruiting nowThis research is being done to see if we can improve the outcome of prostate cancer patients who present with metastatic lesions at initial diagnosis.
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug aims to wipe out lingering leukemia cells after chemo
Disease control OngoingA single-center, single-arm, open-label, interventional, phase II clinical trial to evaluate the efficacy and safety of InO in B-ALL achieved CR/CRi after 1L induction chemotherapy with positive minimal residual disease.
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New hope for kids with severe eczema: drug trial shows promise
Disease control OngoingThe main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18 years of age with moderate-to-severe atopic dermatitis (AD).
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New drug candidate AGSAVI aims to lower stubborn high blood pressure
Disease control CompletedA multicenter, Randomized, Double-blind, Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients with Essential Hypertension Inadequately Controlled with AGLS
Phase 3 • Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New rapid test could free TB patients from isolation sooner
Diagnosis CompletedThe objective of the present study is to confirm in a multicentric study the utility of our viability test in large cohort of smear-positive pulmonary tuberculosis patients under treatment and to determine if the test could help physicians to discontinue isolation measures in hos…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jul 15, 2026 00:00 UTC
-
Can a text message stop impaired driving?
Prevention CompletedSubstance-Impaired Driving among emerging adults remains a significant public health concern and may be the single riskiest substance-related outcome among young adults. Brief Interventions (BIs) have been shown to reduce alcohol-impaired driving among this age group, but are not…
Sponsor: Western Kentucky University • Aim: Prevention
Last updated Sep 02, 2026 00:00 UTC
-
New cocktail of drugs shows promise for tough bile duct cancer
Disease control Recruiting nowIn this phase 2 study, the investigators aim to evaluate the effects and safety of combined therapy using oxaliplatin and gemcitabine chemotherapy, Donafenib and Tislelizumab for patients with advanced biliary tract carcinoma.
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
A personal pain coach may cut opioid risks after hand and arm injuries
Symptom relief CompletedThis is a randomized control trial aimed at learning more about LCS position and the value it provides to the patient's who have sustained upper extremity traumas.
Sponsor: Emory University • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Cord milking may save newborn brains: major trial underway
Knowledge-focused OngoingThe investigators will conduct a study on non-vigorous infants at birth to determine if umbilical cord milking (UCM) results in lower rate of moderate to severe hypoxic ischemic encephalopathy (HIE) or death than early clamping and for infants who are non-vigorous at birth and ne…
Sponsor: Nemours Children's Clinic • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
New hope for Hard-to-Treat myeloma: cevostamab trial underway
Disease control OngoingThis study will evaluate the efficacy, safety, and pharmacokinetics of cevostamab in participants with relapsed or refractory multiple myeloma (R/R MM) via intravenous (IV) infusion.
Phase 1/2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Blood test guides chemo timing in head and neck cancer trial
Disease control Recruiting nowBy doing this study, the research team would like to learn if using a blood test that measures the amount of tumor DNA in blood can help guide how to use chemotherapy combined with immunotherapy for individuals with head and neck cancer. Using this blood test, the research team h…
Phase 2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
ER-Based counseling aims to curb youth suicide
Symptom relief Recruiting nowThis randomized comparative effectiveness trial will compare two evidence-based approaches to emergency care for youth ages 13-24 who present to the Emergency Department (ED) with suicidal ideation or behavior. Outcomes will be monitored at baseline and at 3, 6 \& 12 month follow…
Phase 2 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
A 3-Session parenting fix for child behavior problems?
Disease control Recruiting nowRATIONALE: The access to and uptake of evidence-based behavioral parent training for children with behavioral difficulties (i.e., oppositional, defiant, aggressive, hyperactive, impulsive, and inattentive behavior) are currently limited because of a scarcity of certified therapis…
Sponsor: Accare • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Could a neck nerve block cut heart surgery complications?
Symptom relief CompletedIn this study, Valve replacement patients undergoing cardiopulmonary bypass were randomly divided into control group and experimental group (SGB Group) , main outcome measures: postoperative complications (pulmonary infection, oxygenation injury, arrhythmia, hemorrhage, enteropar…
Sponsor: Zhonghua Chen,MD • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC